» Articles » PMID: 35034238

The Cost-Effectiveness of HIV/STI Prevention in High-Income Countries with Concentrated Epidemic Settings: A Scoping Review

Overview
Journal AIDS Behav
Date 2022 Jan 16
PMID 35034238
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this scoping review is to establish the state of the art on economic evaluations in the field of HIV/STI prevention in high-income countries with concentrated epidemic settings and to assess what we know about the cost-effectiveness of different measures. We reviewed economic evaluations of HIV/STI prevention measures published in the Web of Science and Cost-Effectiveness Registry databases. We included a total of 157 studies focusing on structural, behavioural, and biomedical interventions, covering a variety of contexts, target populations and approaches. The majority of studies are based on mathematical modelling and demonstrate that the preventive measures under scrutiny are cost-effective. Interventions targeted at high-risk populations yield the most favourable results. The generalisability and transferability of the study results are limited due to the heterogeneity of the populations, settings and methods involved. Furthermore, the results depend heavily on modelling assumptions. Since evidence is unequally distributed, we discuss implications for future research.

Citing Articles

Barriers and facilitators to uptake and use of oral pre-exposure prophylaxis in pregnant and postpartum women: a qualitative meta-synthesis.

Liu Y, Zhang L, Chen H BMC Public Health. 2024; 24(1):1653.

PMID: 38902766 PMC: 11191323. DOI: 10.1186/s12889-024-19168-4.


Estimating the Cost-Effectiveness of HIV Self-Testing in the United States Using Net Benefit Regression.

Islam M, Shrestha R, Hoch J, Farnham P J Acquir Immune Defic Syndr. 2023; 95(2):138-143.

PMID: 37831617 PMC: 11305482. DOI: 10.1097/QAI.0000000000003325.

References
1.
Holtgrave D, Qualls N, Graham J . Economic evaluation of HIV prevention programs. Annu Rev Public Health. 1996; 17:467-88. DOI: 10.1146/annurev.pu.17.050196.002343. View

2.
Rudmik L, Drummond M . Health economic evaluation: important principles and methodology. Laryngoscope. 2013; 123(6):1341-7. DOI: 10.1002/lary.23943. View

3.
Creese A, Floyd K, Alban A, Guinness L . Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet. 2002; 359(9318):1635-43. DOI: 10.1016/S0140-6736(02)08595-1. View

4.
Galarraga O, Colchero M, Wamai R, Bertozzi S . HIV prevention cost-effectiveness: a systematic review. BMC Public Health. 2009; 9 Suppl 1:S5. PMC: 2779507. DOI: 10.1186/1471-2458-9-S1-S5. View

5.
Tran B, Nguyen L, Turner H, Nghiem S, Vu G, Nguyen C . Economic evaluation studies in the field of HIV/AIDS: bibliometric analysis on research development and scopes (GAP). BMC Health Serv Res. 2019; 19(1):834. PMC: 6854742. DOI: 10.1186/s12913-019-4613-0. View